UNITED STATES OF AMERICA
before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 78688 / August 26, 2016
Admin. Proc. File No. 3-17255
In the Matter of
BODISEN BIOTECH, INC.,
CHINA GLOBAL MEDIA, INC.,
CHINA HELI RESOURCE RENEWABLE, INC.,
and GFR PHARMACEUTICALS, INC.

NOTICE THAT INITIAL DECISION HAS BECOME FINAL
The time for filing a petition for review of the initial decision in this proceeding has
expired. No such petition has been filed by Bodisen Biotech, Inc., China Global Media, Inc.,
China Heli Resource Renewable, Inc., or GFR Pharmaceuticals, Inc., and the Commission has
not chosen to review the decision on its own initiative.
Accordingly, notice is hereby given, pursuant to Rule 360(d) of the Commission's Rules
of Practice,1 that the initial decision of the administrative law judge has become the final
decision of the Commission with respect to Bodisen Biotech, Inc., China Global Media, Inc.,
China Heli Resource Renewable, Inc., and GFR Pharmaceuticals, Inc.2 The order contained in
that decision is hereby declared effective. The initial decision ordered that, pursuant to Section

1
2

17 C.F.R. ยง 201.360(d).

Bodisen Biotech, Inc., China Glob. Media, Inc., China Heli Res. Renewable, Inc., and GFR
Pharm., Inc., Initial Decision Release No. 1035 (July 11, 2016), 114 SEC Docket 11, 2016 WL
4035562. The stock symbols and Central Index Key numbers are: BBCZ and 1178552 for
Bodisen Biotech, Inc.; CGLO and 1450015 for China Global Media, Inc.; CRRWF and 1081823
for China Heli Resource Renewable, Inc.; and GFRP and 1096294 for GFR Pharmaceuticals,
Inc.

2

12(j) of the Securities Exchange Act of 1934, the registrations of each class of registered
securities of Respondents Bodisen Biotech, Inc., China Global Media, Inc., China Heli Resource
Renewable, Inc., and GFR Pharmaceuticals, Inc., are revoked.
For the Commission, by the Office of the General Counsel, pursuant to delegated
authority.

Brent J. Fields
Secretary

